Cytotoxicity considerations and electrically tunable release of dexamethasone from polypyrrole for the treatment of back-of-the-eye conditions

Drug Delivery and Translational Research

Volumn 6, Issue 6, 2016, Pages 793-799

  Ramtin, A ^a,b   Seyfoddin, A ^a,c   Coutinho, F P ^a   Waterhouse, G I N ^a,d   Rupenthal, I D ^a   Svirskis, D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b FRESENIUS UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^d MACDIARMID INSTITUTE FOR ADVANCED MATERIALS AND NANOTECHNOLOGY   (New Zealand)

Author keywords

Conducting polymer; Electrically triggered release; Ocular implant; Sequential polymerization; Smart materials; Solvent washing

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; MONOMER; OLIGOMER; POLYPYRROLE; DELAYED RELEASE FORMULATION; DEXAMETHASONE; POLYMER; PYRROLE DERIVATIVE;

ADULT; AGE RELATED MACULAR DEGENERATION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; CYTOTOXICITY; DIABETIC MACULAR EDEMA; DRUG RELEASE; ELECTROSTIMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; POLYMERIZATION; PRIORITY JOURNAL; RETINA PIGMENT CELL; RETINAL PIGMENT EPITHELIUM; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; ULTRAVIOLET SPECTROSCOPY; ADMINISTRATION AND DOSAGE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ELECTROCHEMISTRY; MACULAR DEGENERATION; MACULAR EDEMA;

CELL LINE; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; ELECTROCHEMISTRY; HUMANS; MACULAR DEGENERATION; MACULAR EDEMA; POLYMERIZATION; POLYMERS; PYRROLES;

EID: 85014028318     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-016-0284-0     Document Type: Article

References (26)

1. Coleman HR, Chan C-C, Ferris III FL, Chew EY. Age-related macular degeneration. Lancet. 2008;372(9652):1835–45. doi:10.1016/S0140-6736(08)61759-6.
2. Seyfoddin A, Chan A, Chen WT, Rupenthal ID, Waterhouse GIN, Svirskis D. Electro-responsive macroporous polypyrrole scaffolds for triggered dexamethasone delivery. Eur J Pharm Biopharm. 2015;94:419–26. doi:10.1016/j.ejpb.2015.06.018.
3. Herrero-Vanrell R, Cardillo JA, Kuppermann BD. Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (Auckland, NZ). 2011;5:139–46. doi:10.2147/OPTH.S15783.
4. Wang Y, Wang VM, Chan CC. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye. 2011;25(2):127–39. doi:10.1038/eye.2010.196.
5. Yoshida M, Lahann J. Smart nanomaterials. ACS Nano. 2008;2(6):1101–7. doi:10.1021/nn800332g.
6. Sharma M, Waterhouse GIN, Loader SWC, Garg S, Svirskis D. High surface area polypyrrole scaffolds for tunable drug delivery. Int J Pharm. 2013;443(1–2):163–8. doi:10.1016/j.ijpharm.2013.01.006.
7. Svirskis D, Travas-Sejdic J, Rodgers A, Garg S. Electrochemically controlled drug delivery based on intrinsically conducting polymers. J Control Release. 2010;146(1):6–15.
8. Sadki S, Schottland P, Brodie N, Sabouraud G. The mechanisms of pyrrole electropolymerization. Chem Soc Rev. 2000;29(5):283–93. doi:10.1039/A807124A.
9. Dall’Acqua L, Tonin C, Varesano A, Canetti M, Porzio W, Catellani M. Vapour phase polymerisation of pyrrole on cellulose-based textile substrates. Synth Met. 2006;156(5–6):379–86. doi:10.1016/j.synthmet.2005.12.021.
10. Leprince L, Dogimont A, Magnin D, Demoustier-Champagne S. Dexamethasone electrically controlled release from polypyrrole-coated nanostructured electrodes. J Mater Sci Mater Med. 2010;21(3):925–30. doi:10.1007/s10856-010-4008-6.
11. Zheng W, Razal JM, Spinks GM, Truong V-T, Whitten PG, Wallace GG. The role of unbound oligomers in the nucleation and growth of electrodeposited polypyrrole and method for preparing high strength, high conductivity films. Langmuir. 2012;28(29):10891–7. doi:10.1021/la301701g.
12. Sangian D, Zheng W, Spinks GM. Optimization of the sequential polymerization synthesis method for polypyrrole films. Synth Met. 2014;189:53–6.
13. Vaitkuviene A, Kaseta V, Voronovic J, Ramanauskaite G, Biziuleviciene G, Ramanaviciene A. Evaluation of cytotoxicity of polypyrrole nanoparticles synthesized by oxidative polymerization. J Hazard Mater. 2013;250–251:167–74. doi:10.1016/j.jhazmat.2013.01.038.
14. Saarinen-Savolainen P, Järvinen T, Araki-Sasaki K, Watanabe H, Urtti A. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharm Res. 1998;15(8):1275–80. doi:10.1023/A:1011956327987.
15. Thompson BC, Moulton SE, Ding J, Richardson R, Cameron A, O’Leary S, et al. Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole. J Control Release. 2006;116(3):285–94. doi:10.1016/j.jconrel.2006.09.004.
16. Yoon CO, Sung HK, Kim JH, Barsoukov E, Kim JH, Lee H. The effect of low-temperature conditions on the electrochemical polymerization of polypyrrole films with high density, high electrical conductivity and high stability. Synth Met. 1999;99(3):201–12. doi:10.1016/S0379-6779(98)01494-5.
17. Smith TJ, Pearson PA, Blandford DL, Brown JD, Gions KA, Hollins JL, et al. Intravitreal sustained-release ganciclovir. JAMA Opthalmol. 1992;110(2):255–8.
18. Driot JY, Novack GD, Rittenhouse KD, Milazzo C, Pearson PA. Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period. J Ocul Pharmacol Ther. 2004;20(3):269–75.
19. Guest GH, McFarlane WD. A study of the colorimetric determination of pyrrole with isatin and the application of the method to biological materials. Can J Res. 1939;17b(4):133–8. doi:10.1139/cjr39b-020.
20. Fromm F. Die stufenphotometrische Bestimmung kleiner Pyrrolmengen. Mikrochemie. 1935;17(1):141–54. doi:10.1007/BF02740127.
21. Petersen A, Carlsson T, Karlsson J-O, Jonhede S, Zetterberg M. Effects of dexamethasone on human lens epithelial cells in culture. Mol Vis. 2008;14:1344–52.
22. Sharma M, Svirskis D, Garg S. Advances in drug-delivery systems based on intrinsically conducting polymers. Smart materials for drug delivery: volume 1. R Soc Chem. 2013. p. 283–303.
23. Riss T. Is your MTT assay really the best choice? Promega Corporation. 2014. http://www.promega.com/~/pdf/resources/pubhub/is-your-mtt-assay-really-the-best-choice/. Accessed 17 Aug 2015.
24. Du J, McEwen B, Manji HK. Glucocorticoid receptors modulate mitochondrial function: a novel mechanism for neuroprotection. Commun Integr Biol. 2009;2(4):350–2.
25. Park Y-S, Ohta T, Takeoka S, Yamamoto K, Tsuchida E. Sintered-tantalum electrode modified with polypyrrole by electropolymerization. Bull Chem Soc Jpn. 1993;66(8):2449–51. doi:10.1246/bcsj.66.2449.
26. Ge D, Tian X, Qi R, Huang S, Mu J, Hong S, et al. A polypyrrole-based microchip for controlled drug release. Electrochim Acta. 2009;55(1):271–5. doi:10.1016/j.electacta.2009.08.049.